A delayed COPD prescription highlights Medicare billing confusion


A Texas family received conflicting explanations for a prescription delay: insurance preapproval or a missing diagnostic code. Responsibility remains unresolved.
A delayed prescription in Texas left a family trying to determine which part of Medicare covered the medicine and what was preventing the pharmacy from filling it. In an October 2 report, KFF Health News described conflicting explanations involving insurance preapproval and missing billing information. Responsibility for the delay remains unresolved.
Kenney Blewett’s lung specialist prescribed the medicine on June 2 for breathing problems caused by chronic obstructive pulmonary disease, or COPD. His wife, Cindy, said his frightening breathing episodes had become more frequent. On June 4, Walgreens emailed that an insurance issue had delayed the prescription.
Medicare is the federal health insurance program for people aged 65 and older or with disabilities. Blewett also had a private Medicare Part D plan for prescription drugs. Cindy initially assumed that this plan was holding up the medicine.
But the prescription was for a liquid inhaled through a nebulizer machine that Blewett already owned. Because the medicine was used through that equipment, it fell under Medicare Part B’s durable medical equipment benefit, rather than Part D drug coverage. That distinction determined where the pharmacy needed to bill the prescription.
Cindy said a Walgreens employee initially told her the prescription required prior authorization. This means a medical provider must obtain an insurer’s permission before a patient receives covered treatment. It is different from supplying the information needed to bill a prescription—the problem described in Walgreens’ later explanation.
Cindy said a Walgreens district pharmacy supervisor later told her the pharmacy had tried to process the prescription through Part B on June 2. According to her account, the supervisor said the prescription lacked a necessary diagnostic code from the physician—a code identifying the patient’s condition—and Walgreens requested it from the doctor’s office that day.
An employee at the physician’s practice gave Cindy a different account: the office could not find a fax from Walgreens requesting the code. Cindy also said Medicare told her it had no record of the prescription being billed to Blewett’s Part B coverage.
Walgreens told KFF Health News in late September that it could not comment on individual cases. Blewett’s lung specialist, Rajesh Shetty of LungDocs, did not respond to the outlet’s calls or emails. The conflicting accounts do not establish where communication broke down or who was responsible.
In January 2026, Medicare launched a pilot in six states, including Texas, testing superintelligence to help with preapproval for some healthcare services. As of the October 2 report, the pilot did not impose prior authorization requirements on COPD medicines. It therefore does not explain the reported prescription delay.
Blewett died by suicide on June 7. Cindy said he had struggled with his mental health for a long time and had attempted suicide years earlier. She wondered whether timely treatment could have changed what happened, but the report does not establish that the medication delay caused his death or that receiving the medicine would have prevented it.
Cindy sought answers from Medicare, her husband’s private drug plan, Walgreens and the physician’s office. Her questions about who was responsible for the delay and how it could have been prevented remained unanswered.

Record-low river flows, widespread drought and severe fire weather added pressure on transport, crops and water supplies.
4 min

An international coalition recommends stricter conditions for animal testing, but its statement does not itself change national rules.
2 min

Parliament seeks a longer pause than the European Commission’s earlier one-year proposal. Some obligations could move to 2030 if other EU institutions agree, but the vote itself does not change legal deadlines.
3 min